Last week we posted two articles suggesting that intravenous vitamin C may be of benefit in supporting patients infected with the new coronavirus. Now clinical trials are taking place in China to determine the effectiveness of high dose vitamin C in these cases.
ZhiYong Peng from Zhongnan Hospital is carrying out the trial. He hypothesises that vitamin C infusion will improve the prognosis for coronavirus patients due to its anti-inflammatory properties, as described in our blog posts about coronavirus and sepsis {link to these posts}
The trial will take place over seven days, with some patients receiving an intravenous dose of vitamin C and a control group receiving only water.
As there is currently no targeted antiviral treatment for this virus, the outcome of this study will be very interesting and potentially valuable in the global fight against this disease.